Digitalisation is the reality for each of us in our private life. In laboratories, it’s still a dream. But why are we dreaming of digitalisation and of connectivity between your instruments and your leading systems when these things are actually at our fingertips? The reason might be obvious: when the right tools to connect all software silos are missing, we can’t be digitalised in reality.

Synaptic connections are a fundamental building block of neuronal function, enabling the propagation of activity from one neuronal circuit to another

In this Commentary article, we explore some of the applications of synthetic data generation in the context of healthcare and treatment. Synthetic data can overcome problems surrounding privacy and enable the sharing of important medical information without compromising the privacy of patients.

Digital health is often seen as the 'next big thing' but there are challenges ahead. This month, our discussion group focused on fragmentation, data flow, protection and regulatory approval.

On-Demand Webinar featuring Dr Christos Kannas, Associate Principal Scientist at R&D AstraZeneca & Dr Maya Natarajn, Neo4j Senior Director of Knowledge Graphs

Identifying disease targets, understanding complex biology, and developing effective technologies for target engagement.

In vitro neural models are a proven powerful strategy for the study of neural function and complex disorders of the human nervous system.

Three-dimensional induced pluripotent stem cell (iPSC)-derived in vitro cell models, commonly referred to as spheroids, organoids, or “mini-brains”, more accurately recapitulate the multicellular organization and structure of in vivo tissues when compared to traditional monolayer cell cultures

High throughput screening requires careful validation of assay performance

Comprehensive, high-throughput, in vitro screening of the neurological effects of chemical compounds and drugs is vital for environmental and drug safety

Andrew Robertson, Vice President, Head of Global Regulatory Policy and Innovation at Takeda, talks about working with regulators and the current regulatory paradigm.

Our February Discovery Series discussion group centred on DNA Encoded Libraries (DEL). Using DEL enables the simultaneous screening of thousands of potential drugs against a target.